Apokyn Related Clinical Trials
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) [Completed]
Treatment of Apomorphine-induced Skin Reactions: a Pilot Study [Not yet recruiting]
Infusion of Apomorphine: Long-term Safety Study [Recruiting]
Safety/Efficacy of Tigan� to Control Nausea/Vomiting Experienced During Apokyn� Initiation and Treatment [Completed]
Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO) [Recruiting]
Apomorphine Effects on Experimental Pain [Completed]
Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease [Recruiting]
Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease [Completed]
Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease [Recruiting]
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease [Completed]
Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study [Completed]
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months [Completed]
Low Dose Apomorphine and Parkinsonism [Completed]
Blinking and Yawning in Epilepsy: The Role of Dopamine [Active, not recruiting]
Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy [Completed]
Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods. [Not yet recruiting]
Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease [Completed]
Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury [Suspended]
Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease [Recruiting]
JP-1730 to Treat Parkinson's Disease [Completed]
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist [Completed]
PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Completed]
A Phase 3 Study to Examine the Efficacy, Safety and Tolerability of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease [Recruiting]
A Study to Examine APL-130277 in Patients With Parkinson's Disease [Completed]
Extended Long-Term Safety Study of KW-6500 [Completed]
Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 [Completed]
Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease [Completed]
EMD 128130 for the Treatment of Parkinson's Disease [Completed]
Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients [Completed]
Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study [Active, not recruiting]
|